Amgen (AMGN)
(Delayed Data from NSDQ)
$298.62 USD
+0.12 (0.04%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $301.05 +2.43 (0.81%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Brokerage Reports
Amgen Inc. [AMGN]
Reports for Purchase
Showing records 281 - 300 ( 429 total )
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Healthcare -CD33 Targeting in AML: Three Takeaways from ASH
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J